A Randomized, Comparative Effectiveness Study of Complete Revascularization with Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients with Symptomatic Aortic Valve Stenosis undergoing Elective Transfemoral Transcatheter Aortic Valve Replacement: The COMPLETE TAVR Study,
Role: Investigator,
University of British Columbia,
(04/2024 - 04/2025)
Status: Approved
For Profit Organization
GORE® CARDIOFORM Septal Occluder and Antiplatelet medical management for reduction of recurrent stroke in patients with Patent Foremen Ovale (PFO): The REDUCE post approval study,
Role: Investigator,
W.L. Gore & Associates, Inc.,
(06/2024 - 06/2025)
Status: Approved
Impella®-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial,
Role: Investigator,
ABIOMED, Inc.,
(01/2025 - 01/2026)
Status: Approved